Molecular characterization of circulating tumor cells in human metastatic colorectal cancer.
Metastatic colorectal cancer (mCRC) relies on the detachment of aggressive malignant cells from the primary tumor into the bloodstream and, concordantly, the presence of these Circulating Tumor Cells (CTC) is associated with a poor prognosis. In this work, the molecular characterization of CTC from...
Guardado en:
Autores principales: | Jorge Barbazán, Lorena Alonso-Alconada, Laura Muinelo-Romay, María Vieito, Alicia Abalo, Marta Alonso-Nocelo, Sonia Candamio, Elena Gallardo, Beatriz Fernández, Ihab Abdulkader, María de Los Ángeles Casares, Antonio Gómez-Tato, Rafael López-López, Miguel Abal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/28b3f3215fb94b26a6060573ce85ac50 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Haemodynamic-dependent arrest of circulating tumour cells at large blood vessel bifurcations as new model for metastasis
por: Carlos Casas-Arozamena, et al.
Publicado: (2021) -
Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab
por: Giorgia Marisi, et al.
Publicado: (2017) -
Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer
por: Belén L. Bouzo, et al.
Publicado: (2021) -
Ziv-aflibercept in metastatic colorectal cancer
por: Patel A, et al.
Publicado: (2013) -
Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer
por: Yan-jun Lu, et al.
Publicado: (2017)